📰 GPCR Weekly News, July 31 to August 6, 2023
Greetings, GPCR fellows! Prepare for the latest GPCR updates.
This week's highlights:
Dr. Randy Hall's study: GPR37L1's role in shaping cortical astrocytes during development
Dr. Nichola J Smith's investigation: Gene expression of TAS1R taste receptors for cardiometabolic disease treatment
Drs. Devki D Sukhtankar and Pina M Cardarelli's research: Burixafor Hydrobromide (GPC-100) effects on hematopoietic cells in mice and humans
Mark your calendar! The Dr. GPCR Symposium on 'GPCRs as Therapeutic Modalities' is set for September 22nd. Want to share your project informally? Submit a 1-minute abstract video using this form. Join us for a discussion session on Kumospace, replacing the poster session.
Stay updated with the Dr. GPCR Newsletter for confirmed speaker announcements.
Remember to catch up on the Classified GPCR News from July 31st to August 6th, 2023.
Adhesion GPCRs
GPCR Activation and Signaling
GPCR activation and GRK2 assembly by a biased intracellular agonist
Conserved class B GPCR activation by a biased intracellular agonist
The psychosis risk factor RBM12 encodes a novel repressor of GPCR/cAMP signal transduction
The relaxin receptor RXFP1 signals through a mechanism of autoinhibition
GPCR Binders, Drugs, and more
Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
Development of an Affinity-Based Probe to Profile Endogenous Human Adenosine A3 Receptor Expression
GPCRs in Cardiology, Endocrinology, and Taste
GPCRs in Neuroscience
GPCRs in Oncology and Immunology
GPCRs and fibroblast heterogeneity in fibroblast-associated diseases
Ultrasensitive dose-response for asbestos cancer risk implied by new inflammation-mutation model
Methods & Updates in GPCR Research
Reviews, GPCRs, and more
Structural and Molecular Insights into GPCR Function
Industry News
X4 Pharmaceuticals Closes $115 Million Loan Facility with Hercules Capital
Gene-to-structure and Europe give Proteros customers a winning hand